A nationwide population-based study on prescribing trends published in the Annals of Internal Medicine found a significant increase in new users of GLP-1 receptor agonists who don’t have a diagnosis of type 2 diabetes. The proportion of new GLP-1 users with type 2 diabetes decreased from nearly 90% to about 70% from 2019 to 2023, according to a separate analysis of the findings in MedPage Today. Meanwhile, new users tend to be those prescribed the …
Read More![GLP-1 Drugs Increasingly Used For Weight, Not Diabetes GLP-1 Drugs Increasingly Used For Weight, Not Diabetes](https://www.jucm.com/wp-content/uploads/2024/07/Young-White-Female-in-Green-T-Shirt-Getting-Waist-Measured-by-Young-Female-Provider-Weight-Management-GLP1-Users-380x253-1.jpg)